Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

BeiGene (BGNE) News Today

BeiGene logo
BeiGene announces FDA approval of Tevimbra/chemotherapy combination
BeiGene Announces FDA Approval Of TEVIMBRA - Quick Facts
BeiGene announces FDA approval of Tevimbra
BeiGene, Ltd. stock logo
BeiGene, Ltd. (NASDAQ:BGNE) Receives Average Recommendation of "Moderate Buy" from Analysts
BeiGene, Ltd. (NASDAQ:BGNE - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the eight research firms that are presently covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a hold recommendation and six have assigned a buy r
BeiGene (BGNE) Gets a Buy from TD Cowen
BeiGene, Ltd. stock logo
Stifel Financial Corp Sells 4,366 Shares of BeiGene, Ltd. (NASDAQ:BGNE)
Stifel Financial Corp lessened its stake in shares of BeiGene, Ltd. (NASDAQ:BGNE - Free Report) by 25.4% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 12,807 shares of the company's stock after selling
BeiGene, Ltd. stock logo
Public Employees Retirement System of Ohio Reduces Stock Position in BeiGene, Ltd. (NASDAQ:BGNE)
Public Employees Retirement System of Ohio reduced its position in shares of BeiGene, Ltd. (NASDAQ:BGNE - Free Report) by 73.2% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 11,917 shares of the company's sto
BeiGene, Ltd. stock logo
BeiGene, Ltd. (NASDAQ:BGNE) Sees Significant Increase in Short Interest
BeiGene, Ltd. (NASDAQ:BGNE - Get Free Report) saw a large growth in short interest during the month of November. As of November 30th, there was short interest totalling 1,330,000 shares, a growth of 33.1% from the November 15th total of 999,400 shares. Based on an average daily volume of 367,900 shares, the short-interest ratio is presently 3.6 days.
Tracking Baker Brothers Portfolio - Q3 2024 Update
Remove Ads
Get BeiGene News Delivered to You Automatically

Sign up to receive the latest news and ratings for BGNE and its competitors with MarketBeat's FREE daily newsletter.

BGNE Media Mentions By Week

BGNE Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BGNE
News Sentiment

0.00

0.78

Average
Medical
News Sentiment

BGNE News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BGNE Articles
This Week

1

5

BGNE Articles
Average Week

Remove Ads
Get BeiGene News Delivered to You Automatically

Sign up to receive the latest news and ratings for BGNE and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:BGNE) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners